FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220807866> ?p ?o ?g. }

• W4220807866 abstract "The changes of endothelial function in type 2 diabetes mellitus (T2DM) patients are closely associated with the development of cardiovascular disease (CVD). However, it is still unclear whether commonly used antidiabetic drugs can improve endothelial function. Flow-mediated dilation (FMD) is a noninvasive tool for evaluating endothelial function, which typically examines changes in the brachial artery diameter in response to ischemia using ultrasound. We performed a network meta-analysis (NMA) to explore the associations between changes in endothelial function and antidiabetic drugs by evaluating FMD in T2DM patients.We systematically searched several electronic databases for randomized controlled trials (RCTs) published from inception until January 25, 2022 with no language restriction. The primary outcome was FMD change in all studies, and we performed subgroup analysis in T2DM patients without CVD. NMA was performed to calculate the mean differences (MDs) with 95% confidence intervals (CIs).From the 1,987 candidate articles identified in the initial search, 30 RCTs were eventually included in the analysis. In all studies, glucagon-like peptide-1 receptor (GLP-1R) agonists [MD = 3.70 (1.39-5.97)], TZD [MD = 1.96 (0.006-3.89)] produced improvement of FMD change compared to lifestyle intervention. GLP-1R agonists [MD = 3.33 (1.36-5.34) and MD = 3.30 (1.21-5.43)] showed significantly greater improvements in FMD change in pairwise comparisons with sulfonylureas and placebo. SGLT-2i also showed efficacy compared to sulfonylureas (MD = 1.89, 95% CI, 0.10, 3.75). In studies of T2DM patients without CVD, GLP-1R agonists [MD = 3.53 (1.24-5.76)], and TZD [MD = 2.30 (0.27-3.24)] produced improvements in FMD change compared to lifestyle treatment. GLP-1R agonists [MD = 3.25 (1.13-5.40), and MD = 3.85 (1.68-6.13)] showed significantly greater improvements in pairwise comparisons with sulfonylureas, and placebo.In T2DM patients, both GLP-1R agonists, SGLT-2i and TZD have favorable effects to improve endothelial function in T2DM patients. In T2DM patients without CVD, GLP-1R agonists had a greater effect to improve endothelial function than sulfonylureas. These suggested that GLP-1R agonists are associated with significantly improved endothelial function in T2DM patients." @default.
• W4220807866 created "2022-04-03" @default.
• W4220807866 creator A5008407460 @default.
• W4220807866 creator A5008877702 @default.
• W4220807866 creator A5011541680 @default.
• W4220807866 creator A5027182487 @default.
• W4220807866 creator A5047289105 @default.
• W4220807866 creator A5062405564 @default.
• W4220807866 creator A5071028900 @default.
• W4220807866 creator A5083606012 @default.
• W4220807866 creator A5088869525 @default.
• W4220807866 date "2022-03-17" @default.
• W4220807866 modified "2023-09-30" @default.
• W4220807866 title "Effects of Antidiabetic Drugs on Endothelial Function in Patients With Type 2 Diabetes Mellitus: A Bayesian Network Meta-Analysis" @default.
• W4220807866 cites W1537972189 @default.
• W4220807866 cites W1967385770 @default.
• W4220807866 cites W1990025047 @default.
• W4220807866 cites W1991965065 @default.
• W4220807866 cites W1992237025 @default.
• W4220807866 cites W1996240126 @default.
• W4220807866 cites W2000741080 @default.
• W4220807866 cites W2010699829 @default.
• W4220807866 cites W2021700963 @default.
• W4220807866 cites W2043518164 @default.
• W4220807866 cites W2043551382 @default.
• W4220807866 cites W2046812423 @default.
• W4220807866 cites W2050781927 @default.
• W4220807866 cites W2064130493 @default.
• W4220807866 cites W2065995883 @default.
• W4220807866 cites W2068291692 @default.
• W4220807866 cites W2080167189 @default.
• W4220807866 cites W2086146404 @default.
• W4220807866 cites W2090983717 @default.
• W4220807866 cites W2091836518 @default.
• W4220807866 cites W2099637593 @default.
• W4220807866 cites W2116637754 @default.
• W4220807866 cites W2122880159 @default.
• W4220807866 cites W2126068905 @default.
• W4220807866 cites W2129821518 @default.
• W4220807866 cites W2142433177 @default.
• W4220807866 cites W2151947272 @default.
• W4220807866 cites W2153003051 @default.
• W4220807866 cites W2159316372 @default.
• W4220807866 cites W2159717308 @default.
• W4220807866 cites W2159969745 @default.
• W4220807866 cites W2166977140 @default.
• W4220807866 cites W2170892587 @default.
• W4220807866 cites W2263955246 @default.
• W4220807866 cites W2275204317 @default.
• W4220807866 cites W2338967005 @default.
• W4220807866 cites W2396846174 @default.
• W4220807866 cites W2412800896 @default.
• W4220807866 cites W2425644022 @default.
• W4220807866 cites W2507467604 @default.
• W4220807866 cites W2510211961 @default.
• W4220807866 cites W2519510391 @default.
• W4220807866 cites W2520525899 @default.
• W4220807866 cites W2529195837 @default.
• W4220807866 cites W2535774208 @default.
• W4220807866 cites W2583663683 @default.
• W4220807866 cites W2586020475 @default.
• W4220807866 cites W2606362537 @default.
• W4220807866 cites W2626446274 @default.
• W4220807866 cites W2735947126 @default.
• W4220807866 cites W2756152366 @default.
• W4220807866 cites W2761300333 @default.
• W4220807866 cites W2762278797 @default.
• W4220807866 cites W2766317583 @default.
• W4220807866 cites W2768555410 @default.
• W4220807866 cites W2782989965 @default.
• W4220807866 cites W2795481136 @default.
• W4220807866 cites W2800654584 @default.
• W4220807866 cites W2803804345 @default.
• W4220807866 cites W2809446098 @default.
• W4220807866 cites W2837634082 @default.
• W4220807866 cites W2889111495 @default.
• W4220807866 cites W2900149048 @default.
• W4220807866 cites W2902485108 @default.
• W4220807866 cites W2905322153 @default.
• W4220807866 cites W2952389410 @default.
• W4220807866 cites W2969939526 @default.
• W4220807866 cites W2970787036 @default.
• W4220807866 cites W2971147579 @default.
• W4220807866 cites W2974260792 @default.
• W4220807866 cites W2974450979 @default.
• W4220807866 cites W2989424478 @default.
• W4220807866 cites W2989979295 @default.
• W4220807866 cites W2990309084 @default.
• W4220807866 cites W2990321183 @default.
• W4220807866 cites W3013838418 @default.
• W4220807866 cites W3031500339 @default.
• W4220807866 cites W3092026043 @default.
• W4220807866 cites W3094737477 @default.
• W4220807866 cites W3113948922 @default.
• W4220807866 cites W3139496483 @default.
• W4220807866 cites W4220745692 @default.
• W4220807866 doi "https://doi.org/10.3389/fendo.2022.818537" @default.
• W4220807866 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35370959" @default.
• W4220807866 hasPublicationYear "2022" @default.
• W4220807866 type Work @default.

• next